Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

994 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.
Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Shimada K, Ito S, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Kimura G, Umemura S, Ura N, Hayashi K, Odawara M, Tanahashi N, Ishimitsu T, Kashihara N, Morita S, Teramukai S; COLM Investigators. Ogihara T, et al. Among authors: umemura s. J Hypertens. 2014 Oct;32(10):2054-63; discussiom 2063. doi: 10.1097/HJH.0000000000000281. J Hypertens. 2014. PMID: 24999799 Free PMC article. Clinical Trial.
[Levofloxacin in the field of dermatology].
Kanzaki H, Torigoe R, Yamada T, Abe Y, Shimoe K, Akiyama H, Arata J, Umemura S, Katayama H, Nishihara O, et al. Kanzaki H, et al. Among authors: umemura s. Jpn J Antibiot. 1992 May;45(5):576-84. Jpn J Antibiot. 1992. PMID: 1512944 Japanese.
Lipocalin-type prostaglandin d synthase in essential hypertension.
Hirawa N, Uehara Y, Yamakado M, Toya Y, Gomi T, Ikeda T, Eguchi Y, Takagi M, Oda H, Seiki K, Urade Y, Umemura S. Hirawa N, et al. Among authors: umemura s. Hypertension. 2002 Feb;39(2 Pt 2):449-54. doi: 10.1161/hy0202.102835. Hypertension. 2002. PMID: 11882588
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T; Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators. Iino Y, et al. Among authors: umemura s. Clin Exp Nephrol. 2003 Sep;7(3):221-30. doi: 10.1007/s10157-003-0241-3. Clin Exp Nephrol. 2003. PMID: 14586719 Clinical Trial.
Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension--a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study.
Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchii Y, Uchida S, Kuwahara M, Yamazaki T; Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators. Iino Y, et al. Among authors: umemura s. Hypertens Res. 2004 Jan;27(1):21-30. doi: 10.1291/hypres.27.21. Hypertens Res. 2004. PMID: 15055252 Free article. Clinical Trial.
[Malignant hypertension].
Tamura K, Sakai M, Tanaka Y, Tsurumi Y, Umemura S. Tamura K, et al. Among authors: umemura s. Nihon Rinsho. 2005 Mar;63 Suppl 3:137-42. Nihon Rinsho. 2005. PMID: 15813058 Review. Japanese. No abstract available.
994 results